View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNeurone Studio 過去の業績この会社の最新の決算報告書はまだ処理中です過去 基準チェック /06Neurone Studioは23.4%の年平均成長率で業績を伸ばしているが、Entertainment業界はgrowingで8.8%毎年増加している。売上は減少しており、年平均57%の割合である。主要情報23.38%収益成長率25.35%EPS成長率Entertainment 業界の成長30.34%収益成長率-57.04%株主資本利益率-540.25%ネット・マージンn/a次回の業績アップデート12 May 2026最近の業績更新お知らせ • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026お知らせ • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025お知らせ • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024お知らせ • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023お知らせ • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022お知らせ • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021すべての更新を表示Recent updatesBuy Or Sell Opportunity • Mar 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to €0.24. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.お知らせ • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026Buy Or Sell Opportunity • Jan 16Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.25. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.Buy Or Sell Opportunity • Dec 31Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €0.23. The fair value is estimated to be €0.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€672.0k market cap, or US$781.2k). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding).Buy Or Sell Opportunity • Dec 08Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €0.22. The fair value is estimated to be €0.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.お知らせ • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€909.9k market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).New Risk • Sep 05New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€671.6k market cap, or US$789.4k).New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€837.4k market cap, or US$868.5k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change).New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€484.6k market cap, or US$507.7k). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).お知らせ • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.お知らせ • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (€982.7k market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).お知らせ • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.お知らせ • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023お知らせ • Jun 08Neurone Studio S.A., Annual General Meeting, Jun 30, 2022Neurone Studio S.A., Annual General Meeting, Jun 30, 2022, at 13:00 Central European Standard Time.お知らせ • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022Is New 90 Day High Low • Feb 13New 90-day low: €0.71The company is down 22% from its price of €0.92 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 13% over the same period.お知らせ • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021Is New 90 Day High Low • Oct 26New 90-day low: €0.85The company is down 27% from its price of €1.17 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 20% over the same period.Is New 90 Day High Low • Sep 29New 90-day low: €0.85The company is down 14% from its price of €1.00 on 01 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 8.0% over the same period.収支内訳Neurone Studio の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BST:6SH 収益、費用、利益 ( )PLN Millions日付収益収益G+A経費研究開発費30 Sep 25000030 Jun 25000031 Mar 25000031 Dec 24000030 Sep 24000030 Jun 24000031 Mar 24000031 Dec 230-10030 Sep 230-11030 Jun 230-11031 Mar 23000031 Dec 22000030 Sep 22000030 Jun 22000031 Mar 22000031 Dec 21000030 Sep 21000030 Jun 21000031 Mar 21000031 Dec 20000030 Sep 200-20030 Jun 200-20031 Mar 200-20031 Dec 190-20030 Sep 19000030 Jun 19000031 Mar 19000031 Dec 18000030 Sep 180-10030 Jun 180-11031 Mar 180-11031 Dec 170-11030 Sep 17000030 Jun 17000031 Mar 17000031 Dec 160000質の高い収益: 6SHは現在利益が出ていません。利益率の向上: 6SHは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 6SHは利益を出していないが、過去 5 年間で年間23.4%の割合で損失を削減してきた。成長の加速: 6SHの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: 6SHは利益が出ていないため、過去 1 年間の収益成長をEntertainment業界 ( -6.5% ) と比較することは困難です。株主資本利益率高いROE: 6SHは現在利益が出ていないため、自己資本利益率 ( -540.25% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMedia 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/01 19:45終値2026/04/29 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neurone Studio S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
お知らせ • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025
お知らせ • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
お知らせ • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023
お知らせ • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022
お知らせ • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021
Buy Or Sell Opportunity • Mar 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to €0.24. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
お知らせ • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
Buy Or Sell Opportunity • Jan 16Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.25. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
Buy Or Sell Opportunity • Dec 31Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €0.23. The fair value is estimated to be €0.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€672.0k market cap, or US$781.2k). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding).
Buy Or Sell Opportunity • Dec 08Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €0.22. The fair value is estimated to be €0.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
お知らせ • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025
New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€909.9k market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
New Risk • Sep 05New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€671.6k market cap, or US$789.4k).
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€837.4k market cap, or US$868.5k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change).
New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€484.6k market cap, or US$507.7k). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
お知らせ • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.
お知らせ • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (€982.7k market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).
お知らせ • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.
お知らせ • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023
お知らせ • Jun 08Neurone Studio S.A., Annual General Meeting, Jun 30, 2022Neurone Studio S.A., Annual General Meeting, Jun 30, 2022, at 13:00 Central European Standard Time.
お知らせ • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022
Is New 90 Day High Low • Feb 13New 90-day low: €0.71The company is down 22% from its price of €0.92 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 13% over the same period.
お知らせ • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021
Is New 90 Day High Low • Oct 26New 90-day low: €0.85The company is down 27% from its price of €1.17 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 20% over the same period.
Is New 90 Day High Low • Sep 29New 90-day low: €0.85The company is down 14% from its price of €1.00 on 01 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 8.0% over the same period.